Global Microbiome Research Report 2023: Market Booming with Breakthrough Treatments for Recurrent C. Difficile Infection, Fecal Microbial Transplantation (FMT) Emerges as a Game-Changer - ResearchAndMarkets.com

DUBLIN--()--The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering.

The microbiome therapeutics market is successfully commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for recurrent Clostridium difficile infection (Recurrent C. difficile).

While integrated omics-based projects are underway, researchers focus more on differences in gut microbiota between individuals that may be associated with disease expression. Still, they have yet to identify concrete biomarkers. While integrated omics analysis relies on correlation coefficients and algorithms, researchers are employing several omics approaches, and research is shifting from specific strains to multi-strain consortia.

This report covers the efforts of companies involved in the microbiome market. Also, it covers a wide range of topics, including market size, technology trends, applications in sequencing, health food, agriculture, livestock, skincare, industrial processes, regulations, and marketing. Trends in the global microbiome market are also summarized by country (and some areas), and the current market size, competitive landscape, and challenges are analyzed and forecasted for the future.

Countries Covered

  • United States
  • Canada
  • Germany
  • France
  • United Kingdom
  • China
  • Japan
  • India
  • Others

Key Attributes:

Report Attribute Details
No. of Pages 69
Forecast Period 2022 - 2027
Estimated Market Value (USD) in 2022 $71.55 Billion
Forecasted Market Value (USD) by 2027 $120.56 Billion
Compound Annual Growth Rate 11.0%
Regions Covered GlobalĀ 

Key Topics Covered:

Chapter 1. Microbiome Market Trends

1.1 Microbiome Market Summary

1.2 Emerging Integrators

1.3 Major Probiotic Companies

1.4 Examples of Industrial Chains

1.5 Postbiotics

1.6 Regulation

1.7 Technology Platform Overview

1.8 Fecal Microbial Transplantation (FMT)

1.9 Encapsulation Technology

Chapter 2. Analysis by Microbiome application

2.1 Therapeutics

2.2 Diagnosis

2.3 Functional Food

2.4 Skin Care

2.5 Agriculture, Livestock and Fisheries

2.6 Industrial and other

Chapter 3. Trend Analysis by Company

3.1 Seres Therapeutics

3.2 Rebiotix

3.3 Evelo Biosciences

3.4 IFF(DuPont)

3.5 Chr. Hansen

3.6 Nestle

3.7 Probi

3.8 Yakult

3.9 Morinaga

Chapter 4. Market Size Forecast

Chapter 5. Trend Analysis by Country

Chapter 6. Conclusion

6.1. Competitive Environment Analysis

6.2 Digital Platforms and Marketing Strategies

6.3 Conclusion

Companies Mentioned

  • BGI
  • Chr. Hansen
  • DuPont
  • Enterome
  • Evelo Biosciences
  • Gallinee
  • Illumina
  • L'Oreal
  • Morinaga
  • Nestle
  • Probi
  • Rebiotix
  • Seres Therapeutics
  • Vedanta Biosciences
  • Yakult Honsha

For more information about this report visit https://www.researchandmarkets.com/r/jucl1p

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900